Agenda
TUESDAY, SEPTEMBER 15
All Times - EST Time Zone
8:30am // REGISTRATION AND BREAKFAST
9:00am // OPENING REMARKS
9:10am // FIRESIDE CHAT - Greg Simon, Former President of the Biden Cancer Initiative, Former Executive Director of the White House Cancer Moonshot Taskforce, Former Senior VP Worldwide Policy and Patient Engagement at Pfizer chat with Dr. Mikael Dolsten, Former President of Research, Pfizer, Former President of R&D, Wyeth, Former Worldwide Head of Research, Boehringer Ingelheim
9:40am // Corporate Presentation - Neurenati Therapeutics
9:55am // Corporate Presentation - Causeway Therapeutics
10:10am // Corporate Presentation - Cambium Oncology
10:25am // Corporate Presentation - Neuromagen Pharma
10:40am // Corporate Presentation - MetaShape Pharma
10:55am // Corporate Presentation - General Oncology
11:10am // Corporate Presentation - Novelty Nobility
11:25am // Corporate Presentation - KIFFIK Biomedical
11:40am // Corporate Presentation - Codex Labs
11:55am // Corporate Presentation - Microvascular Therapeutics
12:10pm // Corporate Presentation - Targeron Therapeutics
12:25pm // LUNCH BREAK
1:20pm // SPEAKER - Dr. Michael Salgaller, Supervisor, Technology Analysis and Marketing Unit (TAMU) Technology Transfer Center|National Cancer Institute |National Institutes of Health. Topic: Beyond SBIRs, NIH as Your Partner
1:50pm // Corporate Presentation - Allogenetics
2:05pm // Corporate Presentation - Avails Medical
2:20pm // Corporate Presentation - Sustained Therapeutics
2:35pm // Corporate Presentation - Repair Biotechnologies
2:50pm // Corporate Presentation - Scioto Biosciences
3:05pm // Corporate Presentation - Aether Therapeutics
3:20pm // Corporate Presentation - Stingray Therapeutics
3:35pm // Corporate Presentation - MH3D
3:50pm // Corporate Presentation - Merakris Therapeutics
4:05pm // Corporate Presentation - RSP Systems
4:20pm // Corporate Presentation - Neomics Pharmaceuticals
4:35pm // Corporate Presentation - Starton Therapeutics
5:00pm // SPEAKER - Kristin Gerber, Hogan Lovells Cadwalader, Partner. Topic: Preparing for Your First Institutional Financing Round
5:30pm // VENTURE CAPITAL PANEL DISCUSSION. Moderator: Bill Werkmeister, MedInvest. Panelists: Dr. Chris Bardon, Managing Partner, MPM / BioImpact Capital; Karen Harris, Executive Director, Mission Related Investments and Finance, Alzheimer's Drug Discovery Foundation; Philip Sawyer, Managing Partner, Bering Capital; Kaushik Srinivasan, Founding Partner, Cerulean Health
6:15pm // CLOSING REMARKS
6:25pm // RECEPTION
WEDNESDAY, SEPTEMBER 16
All Times - EST Time Zone
8:30am // REGISTRATION AND BREAKFAST
9:00am // OPENING REMARKS
9:10am // KEYNOTE SPEAKER - Dr. Stelios Papadopoulos, Former Vice Chairman of Cowen. Topic: Evolving Biotech IPO Markets: 1979-2026
9:40am // Corporate Presentation - Prima Innovations
9:55am // Corporate Presentation - HedoniaUSA
10:10am // Corporate Presentation - SciTech Development
10:25am // Corporate Presentation - Ordaos
10:40am // Corporate Presentation - Alveolus Bio
10:55am // Corporate Presentation - TAXIS Pharmaceuticals
11:10am // NETWORKING BREAK
11:40am // Corporate Presentation - ImmunePropulsion
11:55am // Corporate Presentation - SLAM Biotherapeutics
12:10pm // Corporate Presentation -
12:25pm // Corporate Presentation - BAMF Health
12:40pm // LUNCH BREAK
1:30pm // STRATEGIC INVESTOR PANEL
2:15pm // NETWORKING BREAK
2:30pm // Corporate Presentation - Geneius Biotechnology
2:45pm // Corporate Presentation - SPEAKER - Dr Ajit Parhi, CSO TAXIS Pharmaceuticals, Postdoctoral Research at U Penn, Principal Investigator, NIAID. Topic: How to Combat Antimicrobial Resistance
3:15pm // SPEAKER - Blake Wison, Partner, Hogan Lovells Cadwalader. Topic: Regulatory Strategy for Emerging Life Sciences Companies
3:45pm // FAMILY OFFICE AND FOUNDATION PANEL DISCUSSION. Moderator: Bill Werkmeister, MedInvest. Panelists: Steven Abernathy, Founder and Chairman, The Abernathy Group Family Office; Rick Lipkin, Founder and Co-Chair, Catalytic Impact Foundation (CIF); Greg Grinberg, CEO, Origin Foundation; Dr. Alfred Slanetz, Director AIM-HI Fund / National Foundation for Cancer Research
4:30pm // CLOSING REMARKS
4:40pm // RECEPTION